Aflibercept for Subjects Who Are Incomplete Responders to Multiple Intravitreal Injections of Ranibizumab, Anti-VegF (The TURF Study)

Trial Profile

Aflibercept for Subjects Who Are Incomplete Responders to Multiple Intravitreal Injections of Ranibizumab, Anti-VegF (The TURF Study)

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Jan 2017

At a glance

  • Drugs Aflibercept (Primary)
  • Indications Age-related macular degeneration
  • Focus Therapeutic Use
  • Acronyms TURF
  • Sponsors Regeneron Pharmaceuticals
  • Most Recent Events

    • 25 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
    • 16 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top